Patients with haematuria (blood in the urine) may be at risk of urogenital cancer. This study assesses the ability of a new urine test (Telomerase Biosensor Technology) to diagnose cancer in patients with haematuria in the hope of improving diagnostic accuracy and minimizing invasive testing.
For a consultation with one of our urologists please call 03 8506 3600 to make an appointment.